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Summary
BACKGROUND: The term “predisposition” is used as an
indication of antimicrobial prophylaxis to prevent infective
endocarditis and as a criterion for diagnosing infective en-
docarditis according to the modified Duke criteria. The cri-
terion for diagnosing infective endocarditis in native valves
is not well defined.
OBJECTIVES: To identify conditions that increase the risk
for infective endocarditis in native valves, for the diagnosis
of infective endocarditis according to the modified Duke
criteria. In parallel, we compared the results with the year
of patient inclusion for each study and echocardiographic
techniques.
RESULTS: Our systematic review included 207 studies
published from January 1970 to August 2015. Studies that
focused on mitral valve prolapse (112 studies), prior infec-
tive endocarditis (96) and bicuspid aortic valve (78) provid-
ed the most data. However, only six (5.3%), three (3.1%)
and one (1.3%) of these studies, respectively, used analyt-
ical statistical methods. Three (2.7%), two (2.1%) and one
(1.3%), respectively, were graded as good quality stud-
ies. Odds ratios (ORs) for developing infective endocardi-
tis were 3.5–8.2 for mitral valve prolapse, and 2.2 and 2.8
for prior infective endocarditis. The hazard ratio for de-
veloping infective endocarditis was 6.3 for bicuspid aortic
valve. The mean prevalence proportion of infective endo-
carditis in patients with these three heart conditions were
8.5% (mitral valve prolapse), 8.3% (prior infective endo-
carditis) and 8.8% (bicuspid aortic valve). The proportions
of publications prior to the publication of the modified Duke
criteria were 81.8, 75.6 and 74%, respectively. Evolution of
the imaging method and echocardiographic technique was
estimated to be considerable for mitral valve prolapse. The
literature review on aortic valve stenosis (46 studies), mi-
tral valve insufficiency (41) and aortic valve insufficien-
cy (39) provided two analytical studies for aortic stenosis.
One study was graded as good quality and reported a haz-
ard ratio 4.9. The mean prevalence of these heart condi-
tions in patients with infective endocarditis were 7.3, 19.9
and 10.2%, respectively. The proportions of publications
prior to the publication of the modified Duke criteria were
78, 75.6 and 79.5%, respectively. The evolution of both
the echocardiographic technique and the categorisation of
valve disease severity was considerable for all three enti-
ties.
CONCLUSIONS: The evidence for native valve heart con-
ditions predisposing to infective endocarditis is mainly
based on studies with only descriptive statistics published
prior to the release of the modified Duke criteria. Mitral
valve prolapse, prior infective endocarditis and bicuspid
aortic valve are frequently cited as predisposing heart con-
ditions for infective endocarditis. The evolution in echocar-
diographic techniques over the past decades and its in-
fluence on diagnosis was considerable for mitral valve
prolapse, aortic stenosis, mitral insufficiency and aortic in-
sufficiency.
Keywords: infective endocarditis, Duke criteria, predis-
posing heart condition
Introduction
The incidence of infective endocarditis has not changed
over the past three decades, despite improvements in health
care [1]. Whereas in the pre-antibiotic era most patients
with infective endocarditis had a history of rheumatic heart
disease, patients at risk nowadays include elderly people
with degenerative valve disease, those with nosocomial
disease and those undergoing haemodialysis treatment.
Predisposing heart conditions were early on recognised
as being associated with infective endocarditis. Several
authors identified underlying cardiac lesions in patients
with infective endocarditis and came to the conclusion that
rheumatic heart disease, mitral valve prolapse, congeni-
tal heart disease and degenerative valve lesions predis-
pose to infective endocarditis [2–6]. With current diagnos-
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tic methods, the term “degenerative valve lesions” includes
a wide spectrum of valvular diseases. Analysing the term
“predisposing heart condition” in native valves from to-
day’s perspective is challenging. Over the past decades, the
technology has improved significantly. Also, definitions of
valvulopathies have changed over the last decades (table
S1 in appendix 1). Thus, it is important to match the ev-
idence for a given heart condition with the corresponding
imaging technique and definition at the time of the corre-
sponding study.
Rationale
The term “predisposing heart condition” is used as an in-
dication for antimicrobial prophylaxis to prevent infective
endocarditis and as a criterion for diagnosing infective en-
docarditis according to modified Duke criteria. The term
for diagnosing infective endocarditis is not well defined.
A recently performed survey with 318 physicians demon-
strated considerable uncertainty about this term [7]. There-
fore, we performed a systematic review and aimed to strat-
ify the results according to study type, year and number
of publications. Thereby, we aimed to identify heart valve
conditions for the Duke criterion “predisposing heart con-
dition” in infective endocarditis, and to analyse the term
from today’s perspective.
Objectives
Our objective was to review the literature according to
PRISMA [10] criteria on specific heart conditions in native
valves predisposing to infective endocarditis. In patients
with specific heart conditions, we aimed to review their
risk for developing infective endocarditis (studies with an-
alytical statistics). In studies with descriptive statistics in-
cluding patients with a specific heart condition, we aimed
to review the proportion with infective endocarditis. On
the basis of the year in which patients were included in a
study, we aimed to review the proportion of studies pub-
lished before and after the release of the modified Duke
criteria. Finally, we aimed to align the results from the
imaging technique available at that time with past and cur-
rent definitions of a specific heart valvular disease.
Methods
Registration
The review protocol was not registered, but has been pub-
lished elsewhere [11].
Eligibility criteria
Heart valve conditions considered relevant for this study
were prior endocarditis, aortic valve stenosis or insuffi-
ciency, bicuspid aortic valve, mitral valve stenosis or in-
sufficiency, mitral valve prolapse, pulmonary valve insuf-
ficiency or stenosis, and tricuspid valve insufficiency or
stenosis. Original articles in English or German published
from 1 January 1970 to 31 July 31 2015 were screened for
eligibility. Articles published after 1970 were included be-
cause von Reyn et al. [9] published criteria on the basis of
infective endocarditis cases that were treated between 1970
and 1977. If the article did not concern adult humans or
concerned diseases other than endocarditis, it was exclud-
ed. Case reports, letters and review articles were excluded.
Information source
A comprehensive, systematic search of the Medline data-
base was performed in August 2015.
Search
To identify relevant articles, we used the following key-
words: “endocarditis”, “predisposing”, “predisposition”,
“risk factor” and “heart condition”. The following search
strategy was used: endocarditis AND (predisposing OR
predisposition OR risk factor OR heart condition). Articles
that were cited by the articles identified in the search were
tracked in the reference list of the corresponding article
and, if relevant, were also included. The retrieved articles
were reviewed and the articles were included or excluded
after screening for predefined criteria.
Study selection process
In a first step, all eligible studies were included, with no
specific criteria concerning participants, interventions, out-
comes or study design. Titles and abstracts were screened
for eligibility, then full papers of relevant articles were
examined in further detail. In a second step, mitral valve
stenosis, pulmonary valve insufficiency or stenosis, and
tricuspid valve insufficiency or stenosis were excluded
from this review because of unknown or low prevalence in
Switzerland. In a third step, results were differentiated be-
tween studies with analytical and descriptive statistics.
Data collection process and data items
For relevant articles, the full text article was reviewed to
extract data concerning the total number of patients/cases
included in the study and the year patient/cases were in-
cluded, as well as patients/cases with specific heart condi-
tions.
Data analyses
In studies with analytical statistics, the method of risk as-
sessment and the focus of the study question was reviewed.
Primary data collection was in Microsoft Excel 2013. Sta-
tistical analysis was conducted in GraphPad Prism (Graph-
Pad Software, La Jolla, CA, USA) and R (www.r-pro-
ject.org).
Categorisation based on the number of included stud-
ies
Empirically, and on the arbitrary basis of 100 desired stud-
ies per valve disease, three categories were predefined,
namely valve diseases with a high (≥75 included studies),
medium (25–74 included studies) and low number of pub-
lications (≤24 included studies). The results were differen-
tiated by the inclusion of patients into studies prior to and
after 2001, the year of publication of the modified Duke
criteria [8].
Summary measures
In a primary analysis of studies with descriptive statistics,
Freeman-Tukey and Begg’s funnel plots were applied to
assess the contribution to heterogeneity and the influence
of each study on the overall results. The results of this pri-
mary analyses are published elsewhere [11]. As a result of
this primary analysis, and owing to the strong heterogene-
ity between the studies, the numbers are presented here
as both mean and median with interquartile range (IQR).
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Studies with calculations of odds ratios or hazard ratios
and not contributing to a large heterogeneity were consid-
ered as good quality.
History and evolution of echocardiography
This theme was reviewed by MH and SZ, is presented else-
where in detail [11] and used here in the context of the year
of publication for each valve disease.
Risk of bias across studies
The literature review was performed by one person only
(AB) and the study selection process was unblinded (AB
and PS).
Results
Study selection
Of 8966 articles, 207 were identified as being eligible for
this systematic review (fig. 1). A detailed list of all includ-
ed studies is available in appendix 1 and online in refer-
ence [11].
Conditions with a high number of publications: mitral
valve prolapse (112 studies), prior infective endocarditis
(96) and bicuspid aortic valve (78) were the most common-
ly described heart conditions predisposing for infective en-
docarditis.
Conditions with a medium number of publications: These
included aortic valve stenosis (46 studies), mitral valve in-
sufficiency (41) and aortic valve insufficiency (39).
Conditions with a low number of publications: These in-
cluded mitral valve stenosis (23 studies), pulmonary valve
stenosis or insufficiency (18), and tricuspid valve stenosis
or insufficiency (9). The latter group paralleled the exclu-
sion criteria for this systematic review and is not presented
here [11].
Study characteristics
The vast majority of studies (>95%) reported epidemiolog-
ical data and descriptive statistics without analytical statis-
tics. Few studies (<5%) presented results from analytical
statistics (table 1). Three-quarters of the studies included
patients at the time period prior to the publication of the
modified Duke criteria [8].
Mitral valve prolapse (table 3 and supplementary table
S2 in appendix 2).
Studies with analytical statistics
We identified six studies with analytical statistics showing
that mitral valve prolapse was associated with a higher
risk of infective endocarditis. The study of Zuppiroli et al.
[16] is not presented in table 2. The authors followed 275
patients with mitral valve prolapse for 10 to 216 months
(mean 98 ± 52 months). One patient developed infective
Figure 1: Algorithm used for systematic literature review.
Table 1: Distribution of studies between publications with descriptive and analytical statistics.
Valve disease Total no. of
studies
Proportion of patients
included in studies pri-
or to the publication of
modified Duke criteria
No. of studies with de-
scriptive statistics only
Proportion of patients
with IE
No. of studies with
analytical statistics
No. of studies with
analytical statistics
and good quality in
the context of the re-
view
Risk calculation
MVP 112 81.8% 110* Mean 8.5%
Median 7.7%
IQR 4.4–11.4%
6* 3 OR 3.5–8.2
see table 2
Prior IE 96 75.5% 94‡ Mean 8.3% Median
7.1%, IQR 4.9–10.2%
3‡ 2 OR 2.2–2.8
BAV 78 74% 77 Mean 8.8% Median
5.6%, IQR 3–12%
1 1 HR 6.3
AS 46 75.6% 45‡ Mean 7.3% Median
6.7%, IQR 2.6–9.7%
2‡ 1 HR 4.9
MI 41 78% 41 Mean 19.9% Median
16%,
IQR 5.2–28.6%
0 – –
AI 39 79.5% 39 Mean 10.2% Median
8.1%, IQR 3.1–16.6%
0 – –
AI = aortic valve insufficiency/regurgitation; AS = aortic valve stenosis; BAV = bicuspid aortic valve; HR = hazard ratio; IE = infective endocarditis; IQR = interquartile range; MI =
mitral valve insufficiency/ regurgitation; MVP = mitral valve prolapse; OR = odds ratio * Four studies used descriptive and analytical statistics. ‡ One study used descriptive and
analytical statistics.
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endocarditis. The authors calculated a risk rate of 0.04
(−0.04 to 0.1) per 100 patient-years. Five studies calcu-
lated odds ratios, two of them in a special context. First,
MacMahon et al. [15] estimated the relative risk of infec-
tive endocarditis associated with the presence of a systolic
murmur in patients with mitral valve prolapse. Second,
Strom et al. [14] aimed to quantitate the risk for infective
endocarditis from dental treatment in patients with cardiac
abnormalities. In both studies, the involved valve in the
overall infective endocarditis population was not specified,
and the odds ratios are considered high with a large 95%
confidence interval. Both studies contributed considerably
to the heterogeneity of data in the preliminary analysis
(presented elsewhere [11]). In the other three studies [3,
12, 13], the odds ratios ranged from 3.5 to 8.2. All six stud-
ies were prior to the release of the modified Duke criteria
[8].
Studies with descriptive statistics
A total of 110 studies were identified that published de-
scriptive statistics on the proportion of patients with mitral
valve prolapse in newly diagnosed infective endocarditis
cases. The mean number of patients included in the 110
studies was 160 (median 111, IQR 72–202). Of the 110
studies, the mean proportion of patients with mitral valve
prolapse was 8.5% (median 7.7%, IQR 4.4–11.4%). Of the
110 studies, 20 (18.2%) enrolled patients after the publica-
tion of the modified Duke criteria [8].
Influence of echocardiography on the diagnosis of valve
pathology
The 1998 definition stated that there was no consensus on
the two-dimensional echocardiographic criteria for mitral
valve prolapse and no single view should be considered di-
agnostic [17]. Meanwhile, echo technique has improved,
and with three-dimensional echocardiography, mitral valve
prolapse can be detected more precisely.
Prior infective endocarditis (table S3 in appendix 2).
Studies with analytical statistics
Three studies used analytical statistics. Todd et al. [18] de-
scribed 29 patients with echocardiographically confirmed
infective endocarditis and 79 controls (with echocardio-
grams) from 2002 to 2004 in the UK. The authors reported
that a patient with prior infective endocarditis has an odds
ratio of 2.2 (95% CI 0.4–10.3, p = 0.383) for developing
infective endocarditis. Alagna et al. [19] reported a study
of 1874 patients from the ICE Cohort from 2000 to 2006
with a 1-year follow-up. Prior infective endocarditis had a
reported odds ratio of 2.8 (95% CI 1.5–5.1) for causing in-
fective endocarditis. Strom et al. [14] reviewed 279 cases
of infective endocarditis from 1988 to 1990 from 54 hos-
pitals in Delaware Valley (USA). Compared with that of
the controls, the odds ratio for developing infective en-
docarditis with prior infective endocarditis in these cases
was 35.2. In a preliminary analysis of heterogeneity (data
shown elsewhere [11]), this study contributed over-propor-
tionately to the heterogeneity.
Studies with descriptive statistics
Ninety-four studies were identified that published descrip-
tive statistics on the proportion of patients with a history
of prior infective endocarditis in newly diagnosed infective
endocarditis cases. Twenty-three (24.5%) of them included
patients only after the publication of the modified Duke
criteria [8]. The mean number of patients included in the
study was 263 (median 122, IQR 80–239).The mean pro-
portion of patients with infective endocarditis plus a his-
tory of previous infective endocarditis was 8.3% (median
7.1%, IQR 4.9–10.2%).
Bicuspid aortic valve (table S4 in appendix 2).
Studies with analytical statistics
Only one study used analytical statistics. Verheugt et al.
[20] described patients from the CONCOR national reg-
istry for adults with congenital heart disease from the
Netherlands, reporting a hazard ratio of 6.3 (95% CI
3.0–13.4).
Table 2: Studies of mitral valve prolapse and infective endocarditis that included analytical statistics.
First author of the
study
Years patients
included
Study method Number of patients with MV IE and
number of
patients with MVP
Number of controls and number of
controls with MVP
OR
(95% CI)
Clemens [3] 1976-1980 Case-control 51 patients with MV IE
13 patients with MVP
153 controls without IE
10 controls with MVP
8.2 (2.4–28.4)
Devereux [12] 1980–1983 Case-control 67 patients with MV IE
11 patients with MVP
196 controls (population control group)
8 controls with MVP
2146 controls (clinical control group)
84 controls with MVP
4.6 (2.0–7.2)
6.7 (1.96–22.9)*
4.8 (2.0–7.2)
6.7 (1.96–22.9)*
Danchin [13] 1981–1986 Case-control 48 patients with MV IE
9 patients with MVP
96 controls
6 controls with MVP
3.5 (1.1 – 10.5)
Strom [14] 1988–1990 Population-based,
case-control†
273 patients with IE
248 patients with native IE‡
52 patients with MVP
273 controls§
6 controls with MVP
19.4 (6.4–58.4)
MacMahon [15] 1976–1984 Case-control¶ 136 patients with IE‡
19 patients with MVP**
17 patients with MVP and murmurs
144 controls††
57 controls with MVP
27 controls with MVP and murmurs
13.0 (2.1–79.0)‡‡
CI = confidence interval; IE = infective endocarditis; MV = mitral valve; MVP = mitral valve prolapse; OR = odds ratio * Matched-triplets analysis. † Aim of the study was to
quantitate the risk of endocarditis from dental treatment and cardiac abnormalities. During the preceding 3 months, dental treatment was similar among case- and control-patients
(adjusted OR, 0.8 [95% CI, 0.4 to 1.5]). ‡ The involved valve (site of infection) of IE was not specified. § One control from the community was selected for each case-patient. ¶ Aim
of the study was to evaluate the risk of IE in patients with MVP with and without precordial systolic murmurs. **The site of infection was the mitral valve in 18 cases and tricuspid
valve in 1 case. †† The control subjects were selected from 144 consecutive patients with echocardiographic MVP. ‡‡ The number reflects the relative risk of IE associated with
presence of a systolic murmur in a patient with MVP.
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Studies with descriptive statistics
Seventy-seven studies were identified that published de-
scriptive statistics on the proportion of patients with a his-
tory of a bicuspid aortic valve in newly diagnosed infective
endocarditis cases. Of these studies, 20 (26%) included pa-
tients after the publication of the modified Duke criteria
[8]. The mean number of patients included in the study
was 185 (median 134, IQR 79–249.5).The mean propor-
tion of patients with a bicuspid aortic valve was 8.8% (me-
dian 5.6%, IQR 3–12%).
Influence of echocardiography on the diagnosis of valve
pathology
In 1974, Nanda et al. [21] had already demonstrated that a
noninvasive diagnosis of bicuspid aortic valve is possible.
Aortic valve stenosis (table S5 in appendix 2).
Studies with analytical statistics
Forty-six studies mentioned aortic stenosis in association
with infective endocarditis, with two that used analytical
statistics. In 2011, Verheugt et al. [20] described patients
from the CONCOR national registry for adults with con-
genital heart disease from the Netherlands and reported
a hazard ratio of 4.9 (95% CI 2.2–10.5). Gersony et al.
[22] reported a study of 462 patients with aortic stenosis
from the second natural history study of congenital heart
defects conducted in the USA between 1958 and 1965,
and a prevalence rate of 21.6 per 10,000 patients (95% CI
0.5–120.6). Follow-up was 8115 person-years, and patients
with conservative management had an infective endocardi-
tis incidence rate of 15.7 per 10,000 person-years (95% CI
6.3–32.4). The authors stated that only the severity of the
aortic stenosis was related to the occurrence of infective
endocarditis.
Studies with descriptive statistics
Of the 45 descriptive studies, 11 (24.4%) included patients
only after the publication of the modified Duke criteria [8].
The mean number of patients included in the study was
242 (median 106, IQR 62–212). Of these studies, the mean
proportion of patients with a history of aortic stenosis was
7.3% (median 6.7%, IQR 2.6–9.7%).
Influence of echocardiography on the diagnosis of valve
pathology
The most important change concerning the echo criteria
was the mean gradient, which defines the severity of aortic
stenosis. The guidelines from 2006 defined severe aortic
stenosis as a mean gradient of ≥40 mm Hg (instead of ≥50
mm Hg in 1998), and the guidelines from 2014 changed
the definition of moderate aortic stenosis to begin at ≥20
mm Hg instead of ≥25 mm Hg. Low-flow, low-gradient
aortic stenosis was first defined in 2006, which is im-
portant for patients with reduced systolic ejection fraction
(table S1 in appendix 1). Developments in echo techniques
and quality (e.g., better screen resolution, better transduc-
ers) also played an important role in diagnostic improve-
ments.
Mitral valve insufficiency (table S6 in appendix 2).
Studies with analytical statistics
None of the studies reported analytical statistical methods.
Studies with descriptive statistics
Forty-one studies were found with mitral insufficiency in
association with infective endocarditis. Nine (22%) includ-
ed patients only after the publication of the modified Duke
criteria [8]. The mean number of patients included in the
study was 288 (median 101, IQR 56–210).The mean pro-
portion of patients with mitral insufficiency was 19.9%
(median 16%, IQR 5.2–28.6%).
Influence of echocardiography on the diagnosis of valve
pathology
The definitions of the grades of mitral insufficiency were
implemented in the 2006 guidelines [23, 24]. Echo criteria
were mentioned previously in the 1998 American Heart
Association (AHA) guidelines concerning the time of
surgery and left ventricle diameters [17].
Aortic valve insufficiency (table S7 in appendix 2).
Studies with analytical statistics
None of the studies reported analytical statistical methods.
Studies with descriptive statistics
Thirty-nine publications with aortic insufficiency in as-
sociation with infective endocarditis were found. Eight
(20.5%) included patients only after the publication of the
modified Duke criteria [8]. The mean number of patients
included in the study was 234 (median 95, IQR 53.5–211).
The mean proportion of patients with a history of aortic in-
sufficiency was 10.2% (median 8.1%, IQR 3.1–16.6%).
Influence of echocardiography on the diagnosis of valve
pathology
Prior to 1998, visualisation by cineangiography and “eye-
ball guessing” of the regurgitant volume was common. In
2003, with recommendations by the American Society of
Echocardiography [24], and later in 2006 with implemen-
tation in the AHA guidelines [23], the echo criteria were
published.
Discussion
For the diagnosis of definite infective endocarditis, Duke
minor criteria play a relevant role when only one major cri-
terion or none of the major criteria are fulfilled. In a study
by Rognon et al. [25], 76% of patients with infective en-
docarditis had a predisposing heart condition as a minor
criterion for the diagnosis. The authors stated that in the
absence of the minor criterion, 27% of definite cases of in-
fective endocarditis would be relegated to lower diagnostic
categories. In a study by Durante-Mangoni et al. [26], the
criterion “predisposing native cardiac condition” was ful-
filled in 29.7% of younger infective endocarditis patients
and in 34.9% of elderly patients. In a study by Habib et al.
[27], the criterion “predisposition, heart disease” was ful-
filled in 71% of patients. It is commonly accepted that cer-
tain heart valve pathologies predispose to infective endo-
carditis. In clinical practice, however, it is unclear which of
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the possible heart pathologies should be counted as Duke
minor criterion. Thus, in the absence of echocardiographic
findings qualifying for a major criterion, definite infective
endocarditis may be over- or underdiagnosed.
The vast majority of the studies (>95%) included in our
systematic review used descriptive statistics only. Only a
few studies investigated a valve pathology as a risk factor
for infective endocarditis with analytical statistics. More-
over, at least three quarters of all included studies involved
patients who presented with infective endocarditis prior to
the publication of the modified Duke criteria [8]. Consid-
ering the evolution of echocardiographic techniques and
classifications of valve disease severity in the past two
decades, it is not surprising that there is substantial confu-
sion on this subject [7].
Here, we reviewed six heart conditions divided into two
categories on the basis of the number of publications. The
rationale for this methodology was developed after we
found only few studies that used analytical statistics, mak-
ing quality assessment difficult. There were a high number
of publications on mitral valve prolapse, prior infective en-
docarditis and bicuspid aortic valve, but less than 5% used
analytical statistics to assess the risk for developing infec-
tive endocarditis. In three studies on mitral valve prolapse,
the odds ratio was 3.5 to 8.2 [3, 12, 13]. For many years,
mitral valve prolapse was diagnosed via auscultation. For
this reason, and considering that 81.8% of the studies were
published prior to the publication of the modified Duke
criteria, the influence of modern echocardiographic tech-
niques on the diagnosis of mitral valve prolapse is likely
to be considerable. We assessed the influence of echocar-
diographic techniques as less relevant for the predisposing
conditions “prior infective endocarditis” and “bicuspid
aortic valve”. Two studies reported an odds ratio of 2.2 and
2.8 for prior infective endocarditis [18, 19] and one a haz-
ard ratio of 6.3 for presence of a bicuspid aortic valve [20]
for developing infective endocarditis.
From today’s perspective, our results on aortic stenosis,
aortic insufficiency and mitral insufficiency are not helpful
for clinical practice. Apart from two publications, we
found no studies that used analytical statistics. We also
assessed the influence of modern echocardiographic tech-
niques on the diagnosis of these valve pathologies (present
or absent) as being high. It was not possible to judge the
influence of the categorisation into mild, moderate or se-
vere valve pathology, because severity was not assessed in
most studies. The evolution of these categories over past
decades was not considered (table S1 in appendix 1), be-
cause three quarters of the studies included patients prior
to the publication of the modified Duke criteria.
Our systematic review has several limitations. It is possible
that our search strategy failed to find additional relevant
publications, as only publications in German and English
were considered and only one database was used to iden-
tify relevant publications. The search did not include grey
literature sources. We did not assess for publication bias.
The literature review included studies with considerable
heterogeneity, as assessed previously [11]. We included
studies with different criteria for infective endocarditis. We
tried to counterbalance this by categorising studies as prior
to 2001 and after 2001. We thereby focused on the years
in which the patients were included in each study and not
on the publication year of the corresponding study. Final-
ly, the categorisation by numbers of publications was arbi-
trary and the number of publications does not necessarily
reflect the quality of studies.
In conclusion, this systematic review demonstrates insuffi-
cient evidence to identify native valve diseases that predis-
pose to infective endocarditis. Mitral valve prolapse, pri-
or infective endocarditis and bicuspid aortic valve had the
highest number of included publications. The numbers of
well-described analytical studies focussing on these valve
pathologies were 3, 2 and 1, respectively. The reported
risks were odds ratios of 3.5 to 8.2 for mitral valve pro-
lapse, ORs of 2.2 and 2.8 for prior infective endocarditis
and a hazard ratio 6.3 for bicuspid aortic valve.
In clinical practice, the diagnostic uncertainty about the
Duke criterion “predisposing heart condition” may lead to
a high suspicion of infective endocarditis in patients with
positive results of blood cultures (e.g., non-staphylococcal
bacteraemia), but inconclusive imaging results. In the early
phase of disease, it may be prudent to over diagnose infec-
tive endocarditis and to perform echocardiography. In the
longer course of the disease, however, overtreatment of in-
fective endocarditis contributes to the development of re-
sistance of organisms in the microbiome and is associated
with adverse effects of antimicrobial agents. This system-
atic review supports (though with little evidence) the view
that it is reasonable to consider mitral valve prolapse, prior
infective endocarditis and bicuspid aortic valve as predis-
posing conditions when infective endocarditis is suspect-
ed at first clinical presentation (i.e., possible infective en-
docarditis). However, over a 2-week period, the clinical
course, microbiological criteria and repeated imaging with
modern techniques should allow confirmation or rejection
of the “definite” diagnosis of infective endocarditis in most
cases, irrespective of the presence of valve disease.
The appendices 1 and 2 can be downloaded from
https://smw.ch/en/article/doi/smw.2018.14675/
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